Isoflavonoid compounds and methods for the treatment of cancer
AssigneeMEI Pharma, Inc.
InventorsGeorge JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
Life of this patent
Estimating the term…
Abstract
Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
Claims9
-15. (canceled)
A pharmaceutical composition comprising d-cis-3-(4-hydroxyphenyl)-4-(4-hydroxyphenyl)-8-methylchroman-7-ol in an enantiomeric excess of greater than 95%.
A kit comprising a composition comprising d-cis-3-(4-hydroxyphenyl)-4-(4-hydroxyphenyl)-8-methylchroman-7-ol in an enantiomeric excess of greater than 95%;
- and
- a sealable, plastic infusion bag.
A method of treating cancer in an individual in need of cancer therapy, the method comprising administering to the individual a composition comprising d-cis-3-(4-hydroxyphenyl)-4-(4-hydroxyphenyl)-8-methylchroman-7-ol in an enantiomeric excess of greater than 95%.
Dependencies are inferred from the claim text.